TOP STORIES this week that Democrats DIDN'T want you to see



There are some stories from the past week that the mainstream media wasn’t jumping to cover — and likely would be quite pleased if you never saw them.

However, Liz Wheeler of “The Liz Wheeler Show” isn’t going to let that happen.

The first story pertains to the Pennsylvania Department of State’s not-so-cryptic post on its X account. It wrote that Pennsylvanians “won’t always know the final results of all races on election night.”

“Any changes in results that occur as counties continue to count ballots are not evidence that an election is ‘rigged,’” the post continued before pointing X users to a government “fact-check” webpage.

“First of all, a government is not supposed to serve as a fact-check. A government is supposed to tell the truth, and journalists are supposed to serve as a fact-check to hold accountable any government officials that are lying,” Wheeler says in disbelief.

“Why is the Pennsylvania Department of State warning us three months before the election that we’re actually not going to know the results of the election on the night of the election?” she asks.

The second story that’s been buried is that Joe Rogan did not endorse RFK Jr. — despite media reports claiming he did.

“In fact, Joe Rogan himself denied that he endorsed RFK Jr. He said he likes the guy, he spoke very highly of the guy, he endorses some of his policies, but he did not endorse him in the sense that Joe Rogan did not say he was going to vote for RFK and that you should vote for RFK,” Wheeler explains.

But the stories get worse — or better, depending on how you look at it.

In a video starring none other than Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases tells the audience that he’s gotten COVID-19 for the third time despite being vaccinated and boosted a total of six times.

“What kind of absolute nutcase gets the COVID vaccine six times? Oh, the kind that gets COVID three times because you’ve shot your immune system,” Wheeler laughs before moving onto the next story — which should surprise no one.

“Kamala Harris copied Donald Trump on his new plan for no tax on tips,” Wheeler explains, adding, “she’s trying to take the wind out of Trump’s sails.”

However, under the Biden administration, more IRS agents were hired in order to make sure that those working in the service industry paid taxes on tips or else they would go after those waiters and waitresses.

“What an absolute liar,” Wheeler says.




Want more from Liz Wheeler?

To enjoy more of Liz’s based commentary, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

CDC Director Rochelle Walensky, who previously said vaccinated people 'don't get sick,' tests positive a month after getting booster shot



CDC Director Rochelle Walensky tested positive for COVID-19 on Friday night.

The Centers for Disease Control and Prevention said in a statement that Walensky was experiencing mild symptoms and was resting at home. Walensky will participate in CDC meetings virtually.

Reuters reported that Walensky was not at the White House at the end of this week and had not met in person with any senior U.S. officials before testing positive for COVID-19.

Walensky attended the World Health Summit in Berlin on Monday and Tuesday – where the CDC director wore a mask at all times except when eating or publicly speaking, according to a spokesperson. Walensky returned to the United States on Wednesday.

The CDC statement said that Walensky was "up to date" with her vaccines.

The U.S. health agency defines "up to date" as: "If you have completed a COVID-19 vaccine primary series and received the most recent booster dose recommended for you by CDC."

The CDC guidance adds, "You are still up to date if you receive all COVID-19 vaccine doses recommended for you and then become ill with COVID-19. You do not need to be immediately revaccinated or receive an additional booster."

Exactly a month ago, Walensky received the bivalent COVID-19 booster vaccine – which is said to provide protection against the original COVID-19 strain and the Omicron variant.

\u201c.@CDCDirector Rochelle Walensky visited a CVS Pharmacy today to get her bivalent COVID-19 booster. The bivalent vaccine provides added protection against COVID-19 and the Omicron variant and is available at CVS Pharmacy locations nationwide. https://t.co/wXDZYrmMyd\u201d
— CVS Health (@CVS Health) 1663881207

In March 2021, Walensky declared that vaccinated people "don't get sick."

“Our data from the CDC today suggests that vaccinated people do not carry the virus, don’t get sick,” Walensky told MSNBC's Rachel Maddow. “And that it’s not just in the clinical trials, it’s also in real-world data.”

Days after Walensky made the comments, the CDC walked the director's remarks back.

“It’s possible that some people who are fully vaccinated could get COVID-19," a CDC spokesperson told the New York Times. "The evidence isn’t clear whether they can spread the virus to others. We are continuing to evaluate the evidence."

\u201cCDC Director Dr. Rochelle Walensky: \u201cOur data from the CDC today suggest that vaccinated people do not carry the virus.\u201d\u201d
— The Recount (@The Recount) 1617125532

Rand Paul challenges Fauci on evidence young people need COVID-19 boosters, and Fauci makes big admission



Sen. Rand Paul (R-Ky.) got White House chief medical adviser Dr. Anthony Fauci to admit there is a lack of data showing that COVID-19 booster shots lower the rates of hospitalization or death in children on Thursday.

Fauci made a virtual appearance before the Senate Health, Education, Labor, and Pensions Committee, where he gave an update to lawmakers on the Biden administration's COVID-19 response. He did not appear in person because he tested positive for the coronavirus earlier this week.

During his question time, Paul noted that the administration recommends that everyone over age five get vaccinated against the coronavirus, including taking a booster shot. "Are you aware of any studies that show reduction in hospitalization or death for children who take a booster?" Paul asked.

"Right now, there's not enough data that has been accumulated, Senator Paul, to indicate that that's the case," Fauci answered. He began to explain that the government's recommendation is based on an "assumption" regarding the morbidity and mortality of children in different age groups, but Paul cut him off.

\u201cRand Paul Destroys Fauci for Recommending Boosters Without Any Data: "If I give a patient ten mRNA vaccines, and they make proteins each time, or they make antibodies each time, is that proof that we should give ten boosters, Dr. Fauci?\u201d\u201d
— Daily Caller (@Daily Caller) 1655408400

"So there are no studies. And Americans should all know this. There are no studies on children showing a reduction in hospitalization or death with taking a booster," Paul said.

The Kentucky lawmaker, an optometrist by training, went on to state that the only research presented to the Biden administration were antibody studies, which he claimed were insufficient to prove the efficacy of booster shots for children. He suggested that a person who receives 10 booster shots of an mRNA vaccine may get antibodies from each shot, but said that does not mean they need 10 boosters.

This prompted pushback from Fauci, who called Paul's example "somewhat of an absurd exaggeration." But Paul asserted that is more or less how the government has supported its booster recommendations.

Acknowledging that "there is probably some indication" that boosters offer protection from hospitalization and death in older people with certain risk factors, Paul said there was no evidence that was the case for younger people. He went on to say that there is a risk of heart inflammation in young people associated with taking mRNA vaccines that, while rare, is concerning.

"The risk of myocarditis with a second dose for adolescent boys 12 to 24 is about 80 in 1 million," Paul said, citing data from the U.S. Centers for Disease Control and Prevention.

"So there is risk and there are risks, and you're telling everybody in America just blindly go out there because we made antibodies,'" Paul said.

FDA suggests future of COVID-19 vaccination may look like a more frequent flu shot



The U.S. Food and Drug Administration says that the currently approved COVID-19 vaccines may need to update their formulas to remain effective against the most recent strains of coronavirus, suggesting that the future of COVID-19 vaccination may be similar to the flu shot.

On Wednesday, the FDA's vaccine advisory committee will meet to discuss "the future course of the pandemic," including what the "optimal strain composition for COVID-19 vaccines" will be and the best schedule for vaccine booster doses among the general population and sub-groups that may be more vulnerable to the virus, according to a briefing document published ahead of the meeting.

The document acknowledges that the current authorized or approved COVID-19 vaccines in the U.S. "are based on the original Wuhan strain" and that "currently circulating SARS-CoV-2 variants harbor mutations" to the virus' spike protein, the feature of a virus that enables it to invade human cells. Studies have shown that these mutations, variants like the B.A. 2 Omicron strain, have reduced the effectiveness of the vaccines currently in use and also that the vaccines have waning efficacy over time, the FDA said.

"New variants are often more infectious, transmissible, and antigenically distinct from earlier virus strains due to accumulated mutations in the [spike] protein that also render them less susceptible to neutralization by antibodies elicited by current COVID-19 vaccines or prior infection by earlier strains of virus," the document states.

During Wednesday's meeting, the FDA's expert advisers will discuss how the agency can develop a transparent process to make recommendations for changing the current composition of the vaccines, if that becomes necessary.

"Although a complete understanding of how emerging SARS-CoV-2 variants impact the effectiveness of current COVID-19 vaccines is lacking, the accumulating data suggest that the composition of vaccines may need to be updated at some point to ensure the high level of efficacy demonstrated in the early vaccine clinical trials," the FDA said.

"An orderly, logical, and transparent process should be delineated for making recommendations for possible changes in COVID-19 vaccine composition and will require the cooperation and collaboration of vaccine manufacturers, vaccine regulators, and global public health laboratories."

When the vaccines were first approved, they showed a 90% efficacy against the original Wuhan strain of coronavirus, according to the U.S. Centers for Disease Control and Prevention. But after the emergence of new variants, including the Delta, Omicron, and B.A. 2 Omicron sub-variants, vaccine efficacy was shown to decline over time.

Citing data from the U.K. Health Security Agency, CNBC News reports that the effectiveness of Pfizer's or Moderna's two-dose vaccines against mild illness caused by the Omicron variant dropped from 70% to just 10% in 25 weeks after the second shot. A booster dose brought protection back up to 75% for about four weeks, but then it fell to between 25% and 40% after 15 weeks.

CDC data shows a corresponding waning efficacy for the vaccines' protection against hospitalization from Omicron. While two vaccine doses initially reduced the incidence of hospitalization by 71%, in five months the effectiveness fell to 54%. A booster dose brought protection back up to 91%, but then it fell again to 78% after four months.

Importantly, the vaccines remain effective at preventing most severe or life-threatening COVID-19 infections and hospitalizations.

For those who are unvaccinated but have previously contracted COVID-19, natural immunity gained from that infection appears to be of longer duration than vaccine-induced immunity, according to an Israeli study. Other studies have shown that the risk of COVID-19 reinfection is low in those with natural immunity and also that vaccination after prior infection can reduce the risk even further.

The Biden administration continues to recommend that all Americans eligible to get vaccinated and receive booster doses do so, especially people with pre-existing health conditions that make them more vulnerable to the virus.

Given uncertainty about how the coronavirus will mutate in the future, the FDA says that clinical trial data to determine safety and efficacy will be necessary before any changes to the current composition of the vaccines are approved. Pfizer and Moderna are currently conducting clinical trials for a new vaccine formula based on the Omicron variant and the BA.2 sub-variant, which has caused a surge of breakthrough infections associated with mild illness in both Europe and the United States.

The FDA briefing document also discusses the timing for additional COVID-19 vaccine booster shots and which groups of people will be eligible for those shots.

The document suggests that in the future, COVID-19 vaccination will be similar to the yearly flu shot, where scientists identify the most likely variant of the virus to circulate seasonally and base that year's vaccine dose on that variant.

"While influenza and coronaviruses are different viruses and will undoubtedly evolve and behave differently in the human population, the process for updating influenza vaccine composition may provide some useful guidelines and considerations for possible updating of COVID-19 vaccine composition," the FDA states.

However, there are important differences between the influenza virus and COVID-19. While the flu has a predictable pattern of emerging each winter, the FDA says "a predictable pattern for a SARS-CoV-2 surge of infections has yet to emerge; for example, Delta and Omicron virus surges in the U.S. were separated by only about 5 months." It is also unclear whether COVID-19 vaccine manufacturers can update the compositions of their vaccines and mass produce them quickly enough to keep up with the evolving virus. Additionally, the flu shot does not need to be tested for safety and efficacy each year, but the COVID-19 vaccines would need testing before each new composition.

These considerations, as well as the role of the World Health Organization in recommending each new COVID-19 vaccine composition, as it does for the flu shot, will be discussed Wednesday.

Last week, U.S. officials authorized a second COVID-19 booster shot (fourth dose) for all Americans over the age of 50, after data showed waning vaccine immunity against the Omicron variants. The FDA said this shot could be administered as early as four months after the first booster dose.

Dr. Peter Marks, an official who leads the FDA office responsible for vaccine safety, said last week that the U.S. may need to offer fourth booster shots for people under 50 in the fall and fifth boosters for those who have already received their fourth dose. He told reporters on a conference call that the extra doses may be necessary as vaccine-induced immunity continues to wane and new virus variants become seasonal.

“It would not be surprising if there is a potential need for people to get an additional booster in the fall along with a more general booster campaign if that takes place,” Marks said. “It may be that a decision is made that rather than the vaccines we currently have, which are called vaccines against the prototype virus, that we will move to a vaccine that is either against one of the variants or something else.”

According to federal data, roughly 45% of Americans who have completed their primary COVID-19 vaccination schedules have also received a booster dose.

FDA authorizes second COVID booster shot for all Americans over the age of 50



The U.S. Food and Drug Administration has given the green light to a second round of booster shots for all Americans over the age of 50, according to various reports.

The decision now lies in the hands of the U.S. Centers for Disease Control and Prevention as to how to implement the new authorization.

What are the details?

According to CNN, the FDA expanded the emergency use authorization of the Pfizer and Moderna COVID-19 vaccines to permit adults aged 50 and older to get a second booster shot.

The shot, according to the report, can be administered as early as four months after their first booster dose.

In a release, Dr. Peter Marks — director of the FDA’s Center for Biologics Evaluation and Research — said, “Current evidence suggests some waning of protection over time against serious outcomes from COVID-19 in older and immunocompromised individuals. Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals. Additionally, the data show that an initial booster dose is critical in helping to protect all adults from the potentially severe outcomes of COVID-19. So, those who have not received their initial booster dose are strongly encouraged to do so.”

What else?

In a statement on the news, a Moderna spokesperson said, "The FDA's endorsement of a second booster dose will allow millions of Americans to build and maintain protection against SARS-CoV-2. The virus continues to evolve, and we are currently on the verge of another potential wave driven by the BA.2 variant. Data continue to show that mRNA boosters remain the best defense against severe infection and death, and vaccines are a foundational part of our public health protection. Now, healthcare providers have the opportunity to advise higher-risk people about when and how to get boosted and build immunity in advance of future outbreaks."

Pfizer, for its part, added, "Together, these data demonstrate the public health need in the most vulnerable individuals and suggest that an additional booster dose of the Pfizer-BioNTech COVID-19 Vaccine administered at least four months after the initial booster will restore antibodies to peak levels, improve protection in older people, and provide a similar safety profile to that of previous doses."

Dr. William Schaffner, infectious diseases expert at Vanderbilt University, said that he believes the U.S. ought to wait until there is a clear and present danger from a new variant or new surge to roll out any fourth doses.

“If you have only one bullet in your gun to shoot, I would prefer to hold fire until the fall, because that’s when cases may really start to increase,” Schaffner said, pointing out that he's very "concerned" that the fourth dose could confuse people who haven't gotten a third dose.

“I’m very concerned about dividing and not being able to conquer because the messaging will get very, very confusing,” he explained. “And so I think public health officials and clinicians ought to be continuing to focus on getting the third dose into people who are eligible.”

sshephard/Getty Images

CDC tells New York Times it hid COVID data for political reasons

Selectively cherry-picking ‘The Science’ to suit a political narrative is not ‘Following the Science.’ It is malpractice and fraud.

Israeli study finds fourth mRNA vaccine dose 'may only have marginal benefits' for young, healthy people



Israeli researchers have found that a fourth mRNA coronavirus vaccine dose is safe but only "somewhat efficacious" against preventing infection from the COVID-19 Omicron variant.

The study, published Wednesday in the New England Journal of Medicine, assessed the efficacy of a fourth dose of either the Pfizer or Moderna vaccines in healthy young health care workers at the Sheba Medical Center. Interim results showed that a fourth shot "is immunogenic, safe, and somewhat efficacious (primarily against symptomatic disease)."

"A comparison of the initial response to the fourth dose with the peak response to a third dose did not show substantial differences in humoral response or in levels of Omicron-specific neutralizing antibodies," the study authors concluded. They suggested that a fourth shot "may have only marginal benefits" when given to healthy young people.

The study did not asses the efficacy of a fourth dose among older and more vulnerable populations.

“Among the approximate 600 participants, 270 of whom received either a fourth dose of the Pfizer vaccine or Moderna vaccine, we found no differences, both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered,” lead study author Prof. Gili Regev-Yochay told the Jerusalem Post.

She said that for both the Pfizer and Moderna vaccines, health care workers who received a fourth dose only had a slightly lower infection rate than those in the control group.

“However, it should be emphasized that the third dose is extremely important for anyone who has not yet contracted COVID-19, and the fourth dose is most likely important for populations with risk factors for which a fourth vaccine would protect from serious illness," Regev-Yochay said.

“This study is added to a series of studies led by Sheba with the aim of providing a scientific basis for managing a pandemic that has wreaked havoc around the globe,” she concluded.

“Thanks to the cohort at Sheba and the plethora of data we have accumulated since the beginning of the pandemic, we continue to lead international studies which shed light on the behavior of the virus and the effectiveness of vaccines and serve decision makers in determining health policy in Israel and around the world.”

Pfizer and BioNTech on Wednesday asked the U.S. Food and Drug Administration to grant an emergency use authorization for a fourth COVID-19 shot for adults age 65 and older who have already received a booster vaccine dose.

In a press release statement, the companies cited the Sheba Medical Center study, as well as additional data from Israel that showed evidence that an additional mRNA booster shot lowered rates of confirmed infections and severe illness.

"An analysis of Israeli Ministry of Health records was conducted for over 1.1 million adults 60 years of age and older who had no known history of SARS-CoV-2 infection and were eligible for an additional (fourth dose) booster. These data showed rates of confirmed infections were 2 times lower and rates of severe illness were 4 times lower among individuals who received an additional booster dose of the Pfizer-BioNTech COVID-19 Vaccine administered at least four months after an initial booster (third) dose compared to those who received only one booster dose," the release said.

New research states that researchers are 'starting to see now diminishing returns on the number of additional doses' of COVID-19 vaccine



New studies have reportedly shown that people may not need a fourth COVID-19 booster shot for months — or even years, depending on the person.

What are the details?

John Wherry, director of the Institute for Immunology at the University of Pennsylvania, told the New York Times for a recent report that researchers are "starting to see now diminishing returns on the number of additional doses" and added that a fourth vaccination may not be necessary for the average adult for a significant period of time.

Wherry added that while people over the age of 65 and those with compromised immune systems may continue to benefit from a fourth dose, it could be unnecessary for most people.

According to the report, scientists say that a third shot of an approved COVID-19 vaccine prompts the human body to manufacture a variety of antibodies that would typically be suitable to fight off various strains and variants of COVID-19.

Dr. Julie McElrath, infectious diseases physician and immunologist at Fred Hutchinson Cancer Research Center in Seattle, told the outlet, “If people are exposed to another variant like Omicron, they now got some extra ammunition to fight it.”

The outlet reported that three doses of a COVID-19 vaccine — even just two for some people — are "enough to protect most people from serious illness and death for a long time" and pointed out that a typical immune system can recall and destroy the virus due to the shots over months to even years.

Dr. Wendy Burgers, immunologist at the University of Cape Town, said that the memory response can "last for ages."

"Potentially the T-cell response is extremely long lived," Burgers added.

What else?

On Monday, NPR global health correspondent Michaeleen Doucleff reported that the current data states that the general population does not need a fourth dose.

"Last week, a study came out of Israel looking specifically at what a fourth dose does," Doucleff said. "How much does it help? It's a preliminary study, and it's pretty small. It included only about 700 people. But it found that quite clearly that a fourth shot of either Pfizer or Moderna doesn't add much protection against infection beyond the third dose. Specifically, it increased protection by only about 10% to 30%, and that protection will likely wane over time."

Doucleff added that more is not necessarily better when it comes to booster shots.

"[T]his vaccine really isn't designed to stop Omicron, stop Omicron infections," she explained. "It's designed to stop the original variants of the virus that circulated two years ago and are very different than Omicron. ... In other words, no matter how many shots you throw at it — four, five, six — it's just not going to stop infections."

Akiko Iwasaki, immunologist at Yale University, added that people in certain demographics — such as elderly, immunocompromised, or who have issues such as obesity or heart disease — would benefit from an additional dose.

"Their immune response is not as robust as a healthy young person, and then that is probably the first target group that would require such a booster," Iwasaki explained.

Fauci warns, 'We may need to boost again.' He proclaims, 'More pain and suffering' for areas not fully vaccinated.



Dr. Anthony Fauci suggested on Sunday that Americans may need more boosters, and painted a grim forecast for areas of the country that are not fully vaccinated.

During an appearance on ABC’s "This Week," host Martha Raddatz expressed optimism regarding the COVID-19 pandemic – citing cases beginning to fall nationally and that certain areas had reached their peak. However, Fauci poured cold water on any enthusiasm regarding the pandemic.

"You know, I think as confident as you can be," Fauci cautioned. "You never want to be overconfident when you're dealing with this virus, Martha, because it has certainly surprised us in the past."

Fauci said he believes that most states will peak by mid-February. He did concede that cases are dropping "rather sharply," and you will "start to see a turnaround throughout the entire country."

However, Fauci followed up with a gloomy forecast for parts of the country.

"There may be a bit more pain and suffering with hospitalizations in those areas of the country that have not been fully vaccinated or have not gotten boosters," warned the director of the National Institute of Allergy and Infectious Diseases (NIAID).

When asked about the need for a fourth booster shot, Fauci responded, "Well, the answer, Martha, honestly, is we don't know because we don't know the durability of protection from the third shot boost of an mRNA and the second shot boost of a J&J. Certainly, you are going to see the antibody levels go down."

Fauci said he had "hope" that the "third shot boost will give a much greater durability of protection."

"We may need to boost again," Dr. Fauci stated. "That's entirely conceivable, but before we make that decision about yet again another boost, we want to determine clearly what the durability of protection is of that regular boost, that third shot that we're talking about."

On Saturday, Pfizer CEO Albert Bourla said that he hoped COVID-19 booster shots could be taken annually instead of every four or five months.

Bourla's admitted that an annual booster is easier to convince people to get than bi-annual shots.

"Once a year — it is easier to convince people to do it. It is easier for people to remember," Bourla told Israel's N12 News. "So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn't forget the other variants and that could be a solution."

Rochelle Walensky says CDC is 'pivoting' the language of what it means to be fully vaccinated



The Centers for Disease Control and Prevention director Dr. Rochelle Walensky said the health agency is pivoting on the CDC's language of what it means to be fully vaccinated against COVID-19.

"And what we really are working to do is pivot the language to make sure that everybody is as up to date with their COVID-19 vaccines as they personally could be, should be, based on when they got their last vaccine," Walensky said during Friday's press briefing from the White House COVID-19 response team.

"So, importantly, right now, we’re pivoting our language," Walensky added. "We really want to make sure people are up to date."

Walensky defined "up to date" as: "That means if you recently got your second dose, you’re not eligible for a booster, you’re up to date. If you are eligible for a booster and you haven’t gotten it, you’re not up to date and you need to get your booster in order to be up to date."

Only weeks ago, Walensky said the CDC is not changing the definition of what it means to be fully vaccinated.

"So, individuals are considered fully vaccinated against COVID-19 if they’ve received their primary series," Walensky said during a Jan. 5 White House press conference. "That definition is not changing."

"But consistent with how public health has historically viewed or even talked about how we recommend vaccines, we are now recommending that individuals stay up to date with additional doses that they are eligible for," the CDC director added.

According to the CDC website, an individual is "up to date" after two doses of the Pfizer-BioNTech or Moderna vaccine, or one dose of the Johnson & Johnson. The CDC does not indicate a booster is required to be fully vaccinated.

Last month, Dr. Anthony Fauci said the definition of what is considered "fully vaccinated" against COVID-19 will inevitably change to include booster shots.

"It's gonna be a matter of when, not if," the definition changes, Fauci said during a CNN interview.

"But when you're talking about optimal protection, there's no doubt now from the data we have, that to be optimally protected you have to get a third shot of an mRNA and a second shot of a J&J," Fauci said during an interview with MSNBC in December.

"The discussion of whether or not the definition of fully vaccinated should include that third shot boost is certainly ongoing and it is certainly on the table," explained the chief medical adviser to President Joe Biden. "I would not be surprised at all if within a reasonable period of time that changes. But right now, we're sticking with the original definition of fully vaccinated."

New York State Gov. Kathy Hochul also proclaimed that she intends to change the definition of "fully vaccinated" to include booster shots.

"At some point, we have to determine that fully vaccinated means boosted as well," Hochul said last month. "And we’ll give people a sufficient timeframe to make that happen."